Stories

As supervisor of the Tissue Registry Archive, Annette Bjorheim finds purpose in her work to provide archived material for patient testing, education, and research needs.

This week's research roundup feature: Development and validation of an acute respiratory distress syndrome prediction model in Coronavirus Disease 2019: Updated lung injury prediction score.

Since March 2019, Paul Jannetto, Ph.D., director of the Metals Laboratory at Mayo Clinic, along with his colleagues across the enterprise and his laboratory staff, have developed, validated, and implemented an artificial intelligence (AI)-augmented test with algorithms designed to interpret kidney stone FTIR spectra. With more than 90,000 kidney stones analyzed each year at Mayo Clinic, this new AI-assisted test has streamlined lab processes and improved patient care.

This week's research roundup feature: Proprotein Convertase Subtilisin/Kexin Type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use.

Wendy is a clinical laboratory technologist who works in the Hematopathology Morphology Laboratory at Mayo Clinic Laboratories. Although she’s worked with Mayo Clinic since 1989, her greatest passion is serving others throughout the community.

This week's Research Roundup feature: Head-to-head comparison of MR elastography-based liver stiffness, fat Fraction, and T1 relaxation time in identifying at-risk NASH.

It’s been more than three years since a team of specialists and genetic testing by Mayo Clinic Laboratories helped pinpoint the cause of Alexa Lofaro’s failing health. And today, she says she continues to feel “so much better” than she did when she first came to Mayo Clinic.

Rachel is a referral specialist serving as the important link between Mayo Clinic Laboratories and our clients. With an eye on quality assurance, she helps patients and clinicians get answers faster.

This week's Research Roundup feature: Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis.

While the accelerated innovation and increased access to testing that’s occurred because of the COVID-19 pandemic has been critically important to worldwide health care, so too has the crash course in laboratory testing and pathology the general public has received throughout the entirety of the pandemic.

Almost four years ago, Mayo Clinic launched the Digital Pathology Program, a major pathology initiative. Phase 2 of this multi-phase rollout has recently been completed, which involved the implementation of cutting-edge digital equipment and software, and converting glass slides of patient samples into digital images. The conversion enables pathologists and laboratory technologists to view, store, retrieve, and share medical images more universally, without waiting for glass slides to be retrieved and delivered. This has significantly improved patient care because pathologists can now discuss cases with clinicians and surgeons in real time.

This week's Research Roundup feature: Renal involvement in systemic sclerosis.

As a field service coordinator at Mayo Clinic Laboratories, Spencer Beekmann spends much of his time onboarding and training new staff on the Client Site Specimen Processing and Regional Service Representative teams. After seven years at Mayo Clinic, Spencer has gained deep respect for the organization’s patient-centric approach to care.